Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuances
Ratios

Aytu Biopharma (AYTU) Short-Term Debt issuances (2021 - 2025)

Historic Short-Term Debt issuances for Aytu Biopharma (AYTU) over the last 5 years, with Q4 2025 value amounting to -$5.8 million.

  • Aytu Biopharma's Short-Term Debt issuances fell 214728.68% to -$5.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $5.1 million, marking a year-over-year increase of 6955.79%. This contributed to the annual value of $6.7 million for FY2025, which is 70144.23% up from last year.
  • Latest data reveals that Aytu Biopharma reported Short-Term Debt issuances of -$5.8 million as of Q4 2025, which was down 214728.68% from $5.8 million recorded in Q3 2025.
  • Over the past 5 years, Aytu Biopharma's Short-Term Debt issuances peaked at $42.2 million during Q3 2021, and registered a low of -$43.0 million during Q4 2021.
  • For the 5-year period, Aytu Biopharma's Short-Term Debt issuances averaged around $63388.9, with its median value being $119500.0 (2022).
  • As far as peak fluctuations go, Aytu Biopharma's Short-Term Debt issuances plummeted by 216542.06% in 2023, and later surged by 98396.4% in 2025.
  • Over the past 5 years, Aytu Biopharma's Short-Term Debt issuances (Quarter) stood at -$43.0 million in 2021, then surged by 98.47% to -$658000.0 in 2022, then surged by 71.28% to -$189000.0 in 2023, then tumbled by 36.51% to -$258000.0 in 2024, then crashed by 2147.29% to -$5.8 million in 2025.
  • Its last three reported values are -$5.8 million in Q4 2025, $5.8 million for Q3 2025, and -$965000.0 during Q2 2025.